Rare-32. clinical outcomes in patients with central neurocytoma

CONCLUSIONS:Central neurocytomas are slow-growing tumors with low rates of recurrence. Genomic characterization of these tumors is needed to identify the molecular features that correlate with recurrence.

Source: Neuro-Oncology - November 6, 2016 Category: Cancer & Oncology Authors: Chukwueke, U., Gill, C., Batchelor, T., Brastianos, P. Tags: RARE TUMORS Source Type: research